Zinc monotherapy increases serum brainderived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial

被引:72
作者
Solati, Zahra [1 ]
Jazayeri, Shima [2 ]
Tehrani-Doost, Mehdi [3 ]
Mahmoodianfard, Salma [1 ]
Gohari, Mahmood Reza [4 ]
机构
[1] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran, Iran
[2] Iran Univ Med Sci, Sch Publ Hlth, Dept Nutr, Tehran 141556117, Iran
[3] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Sch Med, Dept Psychiat, Tehran, Iran
[4] Iran Univ Med Sci, Sch Hlth Management & Med Informat Sci, Dept Stat, Tehran 141556117, Iran
关键词
Zinc; Brain-derived neurotrophic factor (BDNF); Obesity; Depression; BRAIN; SUPPLEMENTATION; NEUROGENESIS;
D O I
10.1179/1476830513Y.0000000105
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Objective: Previous studies have shown a positive effect of zinc as an adjunctive therapy on reducing depressive symptoms. However, to our knowledge, no study has examined the effect of zinc monotherapy on mood. The aim of the present study was to determine the effects of zinc monotherapy on depressive symptoms and serum brain-derived neurotrophic factor (BDNF) levels in overweight or obese subjects. Methods: Fifty overweight or obese subjects were randomly assigned into two groups and received either 30 mg zinc or placebo daily for 12 weeks. At baseline and post-intervention, depression severity was assessed using Beck depression inventory II (BDI II), and serum BDNF and zinc levels were determined by enzyme-linked immunosorbent assay and atomic absorption spectrophotometry, respectively. Results: The trial was completed with 46 subjects. After a 12-week supplementation, serum zinc and BDNF levels increased significantly in the zinc-supplemented group compared with the placebo group. BDI scores declined in both the groups at the end of the study, but reduction in the zinc-supplemented group was significantly higher than the placebo group. More analysis revealed that following supplementation, BDI scores decreased in subgroup of subjects with depressive symptoms (BDI >= 10) (n= 30), but did not change in the subgroup of non-depressed subjects (BDI < 10) (n= 16). Moreover, a significant inverse correlation was observed between serum BDNF levels and depression severity in all participants. Interestingly, a significant positive correlation was found between serum BDNF and zinc levels at baseline. Conclusion: Zinc monotherapy improves mood in overweight or obese subjects most likely through increasing BDNF levels.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 41 条
[1]
Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy [J].
Adachi, Megumi ;
Barrot, Michel ;
Autry, Anita E. ;
Theobald, David ;
Monteggia, Lisa M. .
BIOLOGICAL PSYCHIATRY, 2008, 63 (07) :642-649
[2]
Correlation Between Dietary Zinc Intakes and Its Serum Levels with Depression Scales in Young Female Students [J].
Amani, Reza ;
Saeidi, Somaye ;
Nazari, Zahra ;
Nematpour, Sorour .
BIOLOGICAL TRACE ELEMENT RESEARCH, 2010, 137 (02) :150-158
[3]
Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: preliminary evidences [J].
Araya, A. Veronica ;
Orellana, Ximena ;
Espinoza, Jaime .
ENDOCRINE, 2008, 33 (03) :300-304
[4]
Placebo Effect in Depression [J].
Carpenter, William T. .
AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (08) :935-935
[5]
Role of neurotrophic factors in depression [J].
Castren, Eero ;
Voikar, Vootele ;
Rantamaki, Tomi .
CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (01) :18-21
[6]
The Role of BDNF and Its Receptors in Depression and Antidepressant Drug Action: Reactivation of Developmental Plasticity [J].
Castren, Eero ;
Rantamaki, Tomi .
DEVELOPMENTAL NEUROBIOLOGY, 2010, 70 (05) :289-297
[7]
Cieslik K, 2006, PHARM REP, V59, P46
[8]
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction [J].
Corona, C. ;
Masciopinto, F. ;
Silvestri, E. ;
Del Viscovo, A. ;
Lattanzio, R. ;
La Sorda, R. ;
Ciavardelli, D. ;
Goglia, F. ;
Piantelli, M. ;
Canzoniero, L. M. T. ;
Sensi, S. L. .
CELL DEATH & DISEASE, 2010, 1 :e91-e91
[9]
International physical activity questionnaire:: 12-country reliability and validity [J].
Craig, CL ;
Marshall, AL ;
Sjöström, M ;
Bauman, AE ;
Booth, ML ;
Ainsworth, BE ;
Pratt, M ;
Ekelund, U ;
Yngve, A ;
Sallis, JF ;
Oja, P .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003, 35 (08) :1381-1395
[10]
The placebo effect in neurological disorders [J].
de la Fuente-Fernández, R ;
Schulzer, M ;
Stoessel, AJ .
LANCET NEUROLOGY, 2002, 1 (02) :85-91